"The Cardiac & Vascular Institute is committed to providing the highest quality heart and vascular care to all our patients, utilizing clinical expertise and cutting edge technology in the Cardiovascular field. TCAVI is an accredited testing facility with in-house state-of-the-art equipment. Our cardiologists and vascular surgeons practice under a guiding principle that early detection is the best form of prevention. We look forward to helping with any of your heart and vascular related issues to keep you and your cardiovascular health healthy and strong."

During the past decade, The Cardiac and Vascular Institute Research Foundation conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Cardiac and Vascular Institute Research Foundation" #1 sponsor was "Edwards Lifesciences" with 2 trials, followed by "Boston Scientific Corporation" with 1 trials sponsored, "OrbusNeich" with 1 trials sponsored, "ROX Medical, Inc." with 1 trials sponsored and "Zoll Medical Corporation" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Cardiac and Vascular Institute Research Foundation" #1 collaborator was "ClinLogix. LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "The Cardiac and Vascular Institute Research Foundation" are "Arteriosclerosis" (1 trials), "Cardiovascular Diseases" (1 trials), "Coronary Artery Disease" (1 trials), "Coronary Disease" (1 trials) and "Degenerative Mitral Valve Disease" (1 trials). Many other conditions were trialed in "The Cardiac and Vascular Institute Research Foundation" in a lesser frequency.

Most popular intervention types in "The Cardiac and Vascular Institute Research Foundation" are "Device" (6 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Edwards PASCAL System" (2 trials), "Abbott Mitraclip System" (1 trials), "Arm 1 (ATP+Shock)" (1 trials), "Arm 2 (shock only)" (1 trials) and "Optimal Medical Therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Cardiac and Vascular Institute Research Foundation" are 6 trials for "All" genders.

Currently, there are NaN active trials in "The Cardiac and Vascular Institute Research Foundation". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in The Cardiac and Vascular Institute Research Foundation, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in The Cardiac and Vascular Institute Research Foundation, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".